FilingSEC EDGAR6-K
Evaxion to Present EVX-04 Leukemia Vaccine Data at ASH Meeting
· SEC accepted
StagePreclinical
Filing content
Evaxion will present new target validation data for its AML therapeutic vaccine EVX-04 at the American Society of Hematology (ASH) Annual Meeting in December 2026.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…